P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular...

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Pancreatic ductal adenocarcinoma (PDA) is aggressive with poor survival due to molecular changes.
• P-21-activated kinase 1 (PAK1) and PAK4 are key drivers of PDA tumorigenesis.
• The roles of PAK1 and PAK4 in PDA tumor vasculature and immune response are not well understood.

Purpose of the Study:

• To investigate the effects of PAK1 and PAK4 on PDA tumor vasculature.
• To determine their impact on immune cell infiltration and activation.
• To explore the connection between PAK1/PAK4 knockout and tumor progression.

Main Methods:

• Utilized PAK1-knockout (KO), PAK4 KO, and wild-type (WT) PDA cells in cell-based and mouse models.
• Performed immunohistochemistry on tumor tissues to analyze vasculature and immune cell changes.
• Conducted proteomic studies to assess biological processes and molecular mechanisms.

Main Results:

• PAK1 KO or PAK4 KO suppressed tumor growth by reducing angiogenesis and improving vascular normalization.
• Enhanced infiltration and activation of T-cells and dendritic cells were observed.
• Upregulation of ICAM-1 and VCAM-1 in the tumor microenvironment stimulated vascular immune crosstalk via an ICAM-1-mediated mechanism.

Conclusions:

• PAK1 and PAK4 inhibition promotes tumor vascular normalization and reduces angiogenesis.
• Knocking out PAK1 or PAK4 enhances anti-tumor immune cell infiltration and activation.
• Targeting PAK1/PAK4 presents a potential therapeutic strategy for pancreatic cancer.